Gerresheimer completes Centor sale as Gerresheimer stock costs EUR 27.74

Published on 10/02/2026 at 17:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centor's sale carries an enterprise value of EUR 1.5 billion. Gerresheimer stock costs EUR 27.74 on October 2, 2026 after EUR 27.78.

Schwarzweiß-Reportagefoto einer Qualitätsprüfung von Glasfläschchen — Gerresheimer AG, ISIN DE000A0LD6E6, dokumentiert in Schwarzweiß-Reportage die sorgfältige Qualitätskontrolle pharmazeutischer Glasfläschchen durch Fachpersonal, Illustration mit AI erstellt.

Gerresheimer (ISIN DE000A0LD6E6) completed the sale of its U.S. subsidiary Centor on October 1, 2026, while Gerresheimer stock was trading at EUR 27.74 at Lang & Schwarz on October 2, 2026 at 4:44 p.m. CEST. Deutsche Boerse reported that Gerresheimer will use the proceeds to reduce debt.

Centor sale reduces debt

The transaction covers Centor and the global Primary Packaging Plastics business at a combined enterprise value stated at EUR 1.5 billion. Centor represents about half of that value, while the second transaction is expected to close in the first half of 2027, according to Deutsche Boerse.

Debt reduction is central to the restructuring because management reported net financial debt above EUR 2.0 billion in the second-quarter 2026 earnings call. The planned portfolio leaves Gerresheimer more concentrated in primary packaging and drug delivery systems.

Second-quarter recovery meets pressure

Preliminary revenue reached EUR 578.0 million in the second quarter of 2026, up EUR 55.0 million from the first quarter but down EUR 36.0 million from the second quarter of 2025. Adjusted EBITDA rose from EUR 67.0 million to EUR 102.0 million sequentially, an increase of 52.24 percent, according to FT.com.

The adjusted EBITDA margin was 17.60 percent in the second quarter of 2026, while free cash flow before mergers and acquisitions was negative EUR 92.0 million. Management reaffirmed full-year 2026 organic revenue guidance in the lower half of the EUR 2.3 billion to EUR 2.4 billion range and an adjusted EBITDA margin of 17.00 percent to 18.00 percent, as Investing.com reported on September 30, 2026.

Analyst target below market price

Jefferies maintained a Hold rating and set a EUR 26.80 price target on September 30, 2026, according to Markets Insider. That target was 3.39 percent below the Lang & Schwarz price, making debt execution and cash conversion important markers for the investment case.

Stock stays below yearly high

Gerresheimer was trading at EUR 27.74 at Lang & Schwarz on October 2, 2026 at 4:44 p.m. CEST, down 0.14 percent versus the EUR 27.78 prior close dated October 1, 2026. The primary-exchange context shows a 52-week range of EUR 14.83 to EUR 38.32 and market capitalization of EUR 958.1 million as of October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.